Pharmacologic prevention and treatment of delirium in intensive care patients: A systematic review

Journal of Critical Care

Volumn 30, Issue 4, 2015, Pages 799-807

  Serafim, Rodrigo B ^a,b,c   Bozza, Fernando A ^a,d   Soares, Marcio ^a,e   do Brasil, Pedro Emanuel A A ^a   Tura, Bernardo R ^a   Ely, E Wesley ^f,g   Salluh, Jorge I F ^a,e  

^a D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^b Hospital Copa D'Or   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Funda??o Oswaldo Cruz   (Brazil)

^e INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Tennessee Valley Veteran's Affairs Geriatric Research Education Clinical Center (GRECC)   (United States)

Author keywords

Delirium; ICU; Prevention; Surgical

Indexed keywords

DEXMEDETOMIDINE; HALOPERIDOL; QUETIAPINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; RISPERIDONE; RIVASTIGMINE;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL EFFECTIVENESS; CRITICALLY ILL PATIENT; DATA ANALYSIS; DELIRIUM; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LENGTH OF STAY; NEUROPROTECTION; PATIENT ASSESSMENT; PREVALENCE; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TERMINAL DISEASE; TREATMENT DURATION; CRITICAL ILLNESS; INTENSIVE CARE; INTENSIVE CARE UNIT; POSTOPERATIVE COMPLICATIONS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; CRITICAL CARE; CRITICAL ILLNESS; DELIRIUM; DEXMEDETOMIDINE; HALOPERIDOL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; LENGTH OF STAY; NEUROPROTECTIVE AGENTS; POSTOPERATIVE COMPLICATIONS; QUETIAPINE FUMARATE; RESPIRATION, ARTIFICIAL; RISPERIDONE; RIVASTIGMINE; TREATMENT OUTCOME;

EID: 84930934677     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2015.04.005     Document Type: Article

References (47)

1. Ely E.W., Stephens R.K., Jackson J.C., Thomason J.W., Truman B., Gordon S., et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004, 32:106-112.
2. Pandharipande P.P., Girard T.D., Jackson J.C., Morandi A., Thompson J.L., Pun B.T., et al. Long-term cognitive impairment after critical illness. N Engl J Med 2013, 369:1306-1316.
3. Salluh J.I., Soares M., Teles J.M., Ceraso D., Raimondi N., Nava V.S., et al. Delirium epidemiology in critical care (DECCA): an international study. Crit Care 2010, 14:R210.
4. Girard T.D., Pandharipande P.P., Carson S.S., Schmidt G.A., Wright P.E., Canonico A.E., et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010, 38:428-437.
5. Milbrandt E.B., Deppen S., Harrison P.L., Shintani A.K., Speroff T., Stiles R.A., et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004, 32:955-962.
6. Pisani M.A., Kong S.Y., Kasl S.V., Murphy T.E., Araujo K.L., Van Ness P.H. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009, 180:1092-1097.
7. Saczynski J.S., Marcantonio E.R., Quach L., Fong T.G., Gross A., Inouye S.K., et al. Cognitive trajectories after postoperative delirium. N Engl J Med 2012, 367:30-39.
8. Inouye S.K., Bogardus S.T., Charpentier P.A., Leo-Summers L., Acampora D., Holford T.R., et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999, 340:669-676.
9. Marcantonio E.R., Flacker J.M., Wright R.J., Resnick N.M. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001, 49:516-522.
10. Vasilevskis E.E., Ely E.W., Speroff T., Pun B.T., Boehm L., Dittus R.S. Reducing iatrogenic risks: ICU-acquired delirium and weakness-crossing the quality chasm. Chest 2010, 138:1224-1233.
11. Hipp D.M., Ely E.W. Pharmacological and nonpharmacological management of delirium in critically ill patients. Neurotherapeutics 2010, 9:158-175.
12. Barr J., Fraser G.L., Puntillo K., Ely E.W., Gelinas C., Dasta J.F., et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013, 41:263-306.
13. Patel R.P., Gambrell M., Speroff T., Scott T.A., Pun B.T., Okahashi J., et al. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 2009, 37:825-832.
14. Salluh J.I., Dal-Pizzol F., Mello P.V., Friedman G., Silva E., Teles J.M., et al. Delirium recognition and sedation practices in critically ill patients: a survey on the attitudes of 1015 Brazilian critical care physicians. J Crit Care 2009, 24:556-562.
15. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-e34.
16. Moher D., Hopewell S., Schulz K.F., Montori V., Gotzsche P.C., Devereaux P.J., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2010, 10:28-55.
17. Higgins J.P., Altman D.G., Gotzsche P.C., Juni P., Moher D., Oxman A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928.
18. Gamberini M., Bolliger D., Lurati Buse G.A., Burkhart C.S., Grapow M., Gagneux A., et al. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery-a randomized controlled trial. Crit Care Med 2009, 37:1762-1768.
19. Katznelson R., Djaiani G.N., Borger M.A., Friedman Z., Abbey S.E., Fedorko L., et al. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology 2009, 110:67-73.
20. Maldonado J.R., Wysong A., van der Starre P.J., Block T., Miller C., Reitz B.A. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 2009, 50:206-217.
21. Pandharipande P.P., Pun B.T., Herr D.L., Maze M., Girard T.D., Miller R.R., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298:2644-2653.
22. Riker R.R., Shehabi Y., Bokesch P.M., Ceraso D., Wisemandle W., Koura F., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301:489-499.
23. Rubino A.S., Onorati F., Caroleo S., Galato E., Nucera S., Amantea B., et al. Impact of clonidine administration on delirium and related respiratory weaning after surgical correction of acute type-A aortic dissection: results of a pilot study. Interact Cardiovasc Thorac Surg 2009, 10:58-62.
24. Shehabi Y., Grant P., Wolfenden H., Hammond N., Bass F., Campbell M., et al. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study). Anesthesiology 2009, 111:1075-1084.
25. Wang W., Li H.L., Wang D.X., Zhu X., Li S.L., Yao G.Q., et al. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial*. Crit Care Med 2012, 40:731-739.
26. Hakim S.M., Othman A.I., Naoum D.O. Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial. Anesthesiology 2012, 116:987-997.
27. Prakanrattana U., Prapaitrakool S. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 2007, 35:714-719.
28. van den Boogaard M., Schoonhoven L., van Achterberg T., van der Hoeven J.G., Pickkers P. Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Crit Care 2013, 17:R9.
29. Mariscalco G., Cottini M., Zanobini M., Salis S., Dominici C., Banach M., et al. Preoperative statin therapy is not associated with a decrease in the incidence of delirium after cardiac operations. Ann Thorac Surg 2012, 93:1439-1447.
30. Mardani D., Bigdelian H. Prophylaxis of dexamethasone protects patients from further post-operative delirium after cardiac surgery: a randomized trial. J Res Med Sci 2013, 18:137-143.
31. Page V.J., Ely E.W., Gates S., Zhao X.B., Alce T., Shintani A., et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2013, 1:515-523.
32. Page V.J., Davis D., Zhao X.B., Norton S., Casarin A., Brown T., et al. Statin use and risk of delirium in the critically ill. Am J Respir Crit Care Med 2014, 189:666-673.
33. van Eijk M.M., Roes K.C., Honing M.L., Kuiper M.A., Karakus A., van der Jagt M., et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010, 376:1829-1837.
34. Devlin J.W., Roberts R.J., Fong J.J., Skrobik Y., Riker R.R., Hill N.S., et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010, 38:419-427.
35. Reade M.C., O'Sullivan K., Bates S., Goldsmith D., Ainslie W.R., Bellomo R. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009, 13:R75.
36. Skrobik Y.K., Bergeron N., Dumont M., Gottfried S.B. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004, 30:444-449.
37. Atalan N., Efe Sevim M., Akgun S., Fazliogullari O., Basaran C. Morphine is a reasonable alternative to haloperidol in the treatment of postoperative hyperactive-type delirium after cardiac surgery. J Cardiothorac Vasc Anesth 2013, 27:933-938.
38. Clegg A., Young J.B. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 2011, 40:23-29.
39. Ely E.W., Gautam S., Margolin R., Francis J., May L., Speroff T., et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001, 27:1892-1900.
40. van den Boogaard M., Pickkers P., Slooter A.J., Kuiper M.A., Spronk P.E., van der Voort P.H., et al. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ 2012, 344:e420.
41. Pandharipande P., Shintani A., Peterson J., Pun B.T., Wilkinson G.R., Dittus R.S., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006, 104:21-26.
42. Dasta J.F., Kane-Gill S.L., Pencina M., Shehabi Y., Bokesch P.M., Wisemandle W., et al. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 2010, 38:497-503.
43. Bohner H., Schneider F. Delirium in older persons. N Engl J Med 2006, 354:2509-2511. [author reply 2509-2511].
44. Flaherty J.H., Gonzales J.P., Dong B. Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review. J Am Geriatr Soc 2012, 59(Suppl. 2):S269-S276.
45. Klein Klouwenberg P.M., Zaal I.J., Spitoni C., Ong D.S., van der Kooi A.W., Bonten M.J., et al. The attributable mortality of delirium in critically ill patients: prospective cohort study. BMJ 2014, 349:g6652.
46. Patel S.B., Poston J.T., Pohlman A. Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit. Am J Respir Crit Care Med 2014, 189(6):658-665.
47. Parmar M.K., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17:2815-2834.